These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20939795)

  • 1. The therapeutic implications of renin-angiotensin system blockade in diabetic retinopathy.
    Jeganathan VS
    Curr Pharm Biotechnol; 2011 Mar; 12(3):392-5. PubMed ID: 20939795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of diabetic retinopathy and the renin-angiotensin system.
    Funatsu H; Yamashita H
    Ophthalmic Physiol Opt; 2003 Nov; 23(6):495-501. PubMed ID: 14622351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets.
    Steckelings UM; Rompe F; Kaschina E; Unger T
    Fundam Clin Pharmacol; 2009 Dec; 23(6):693-703. PubMed ID: 19817870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does renin-angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review.
    Sjølie AK; Dodson P; Hobbs FR
    Int J Clin Pract; 2011 Feb; 65(2):148-53. PubMed ID: 21235695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the angiotensin II type 1 receptor in the pathogenesis of diabetic retinopathy: effects of blood pressure control and beyond.
    Clermont A; Bursell SE; Feener EP
    J Hypertens Suppl; 2006 Mar; 24(1):S73-80. PubMed ID: 16601577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for angiotensin receptor blockers in diabetic retinopathy.
    Sjølie AK
    Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S31-9. PubMed ID: 17321627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the renin-angiotensin system and retinopathy.
    Chaturvedi N
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i29-31:discussion i50. PubMed ID: 10956318
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin converting enzyme inhibition: from viper to patient.
    Komajda M; Wimart MC
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i11-4:discussion i50. PubMed ID: 10956312
    [No Abstract]   [Full Text] [Related]  

  • 10. The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy.
    Sjølie AK; Chaturvedi N
    J Hum Hypertens; 2002 Aug; 16 Suppl 3():S42-6. PubMed ID: 12140727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis.
    Wang B; Wang F; Zhang Y; Zhao SH; Zhao WJ; Yan SL; Wang YG
    Lancet Diabetes Endocrinol; 2015 Apr; 3(4):263-74. PubMed ID: 25660574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blockade of the renin-angiotensin system by a combination of ACE inhibitors and AT1 receptor antagonists].
    Azizi M
    Rev Prat; 2004 Jun; 54(11):1167-74. PubMed ID: 15496022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the renin-angiotensin system, with particular reference to dual blockade treatment.
    Andersen NH; Mogensen CE
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):146-52. PubMed ID: 11881115
    [No Abstract]   [Full Text] [Related]  

  • 15. Renin-angiotensin blockade in diabetic retinopathy.
    Ghattas A; Lip PL; Lip GY
    Int J Clin Pract; 2011 Feb; 65(2):113-6. PubMed ID: 21235693
    [No Abstract]   [Full Text] [Related]  

  • 16. Renin angiotensin system (RAS) blockade and diabetic microvascular complications in the eye and kidney.
    Bilous R
    Prim Care Diabetes; 2008 Dec; 2(4):201-2. PubMed ID: 18760685
    [No Abstract]   [Full Text] [Related]  

  • 17. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The renin-angiotensin system and diabetic retinopathy.
    Kohner EM
    Klin Wochenschr; 1992; 69 Suppl 29():25-7. PubMed ID: 1614187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ; Smith SM; Choksi R
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin inhibition--benefit beyond hypertension control.
    Kher V
    J Assoc Physicians India; 2009 Jul; 57():518-20, 525. PubMed ID: 20329413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.